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Abstract: Poly(3-hydroxybutyrate), P(3HB), produced from Bacillus cereus SPV using a 
simple glucose feeding strategy was used to fabricate P(3HB) microspheres using a  
solid-in-oil-water (s/o/w) technique. For this study, several parameters such as polymer 
concentration, surfactant and stirring rates were varied in order to determine their effect on 
microsphere characteristics. The average size of the microspheres was in the range of 2 µm 
to 1.54 µm with specific surface areas varying between 9.60 m2/g and 6.05 m2/g. Low 
stirring speed of 300 rpm produced slightly larger microspheres when compared to the 
smaller microspheres produced when the stirring velocity was increased to 800 rpm. The 
surface morphology of the microspheres after solvent evaporation appeared smooth when 
observed under SEM. Gentamicin was encapsulated within these P(3HB) microspheres and 
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the release kinetics from the microspheres exhibiting the highest encapsulation efficiency, 
which was 48%, was investigated. The in vitro release of gentamicin was bimodal, an 
initial burst release was observed followed by a diffusion mediated sustained release. 
Biodegradable P(3HB) microspheres developed in this research has shown high potential 
to be used in various biomedical applications. 
Keywords: Poly(3-hydroxybutyrate); microspheres; controlled drug delivery; gentamicin 
 
1. Introduction 
Polymeric drug delivery systems are designed to deliver drugs to the local site of action for 
extended periods of time, so that the therapeutic levels of drugs with short in vivo half-lives can be 
maintained [1]. In addition, different forms of drug delivery devices are used to reduce the fluctuations 
in plasma drug levels, so a slower and controlled drug release rate can be achieved, which can then 
provide an effective pharmacological response [1,2]. Microencapsulation of a drug within a polymeric 
device, e.g., microspheres is considered as one of the most common methods of drug delivery [3]. 
Drug encapsulated microspheres require less frequent drug administration when compared to the 
conventional dosage forms. Also, drugs encapsulated within microspheres are kept separate from other 
microspheres; as a result multiple drug administration in a single injection can be achieved, which 
would have not been possible otherwise, owing to drug compatibility issues [1]. Apart from being 
orally administered, microspheres can also be administered through a number of parenteral pathways 
such as intraocular, intravenous, intra-arterial, intraspinal and intraosseous [3]. Often the site of 
administration influences the performance of drug delivery due to differences in the local tissue 
environment such as pH and enzyme activity [3]. 
The solvent evaporation method is the most frequently used technique to prepare polymeric 
microspheres for drug delivery. The characteristics of the microspheres produced are largely dependent 
on the type of polymer (hydrophobic/hydrophilic) and drug used. Other processing parameters such as 
solvent type and concentration of the emulsifier, drug/polymer ratio and stirring rate are also known to 
affect the physicochemical properties of the microspheres [4]. For example, surface morphology and 
porosity of hydrophobic microspheres are known to be particularly affected by the processing 
parameters due to which the drug release rate from microspheres is also affected. However, the 
encapsulation efficiency of drugs within hydrophobic microspheres is largely dependent on the type of 
microencapsulation procedure and on the solubility of the drug. For example, in the single emulsion 
method (o/w), a predetermined quantity of the polymer dissolved in the solvent is added to deionized 
water (inner aqueous phase, w1) containing polyvinyl alcohol PVA, which is used as a surfactant for 
the production of microspheres. The solvent is removed from the inner aqueous phase and evaporated 
through the emulsion-air interface. Polymer precipitation is accelerated leading to the formation of the 
final microsphere, once the solvent evaporation is initiated. However, the encapsulation efficiency of 
highly hydrophilic drugs is affected by the fast shrinkage of the microspheres. As a result, the 
encapsulated drug is drained out of the microspheres during solvent removal. Therefore the o/w 
method is more suitable for the entrapment of less hydrophilic drugs as they accumulate towards the 
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microsphere surface due to their hydrophobic nature. In the double emulsion method (w1/o/w2) the 
initial emulsion phase (w1) is added to a second aqueous phase containing PVA (w2). During solvent 
evaporation, small microdroplets formed within the microspheres coalesce forming a honeycomb 
structure. During solvent evaporation, the precipitating polymer wall also forms holes through which 
the entrapped drug is partly removed. This honeycomb structure is considered most suitable for 
efficient entrapment of hydrophilic drugs [5].  
The double emulsion method has been used by several researchers to entrap highly hydrophilic 
drugs such as gentamicin within biodegradable hydrophobic microspheres [6,7]. Gentamicin, a highly 
water soluble drug, is an aminoglycoside that has been used against a wide range of Gram-positive and 
Gram-negative bacteria [7]. For example, gentamicin has been used for the treatment of osteomyelitis, 
an inflammatory bone disease [7]. Osteomyelitis is the microbial infection of the bone medullary 
cavity, cortex and periosteum that is known to occur during post-operative sepsis after an orthopaedic 
procedure. However, for the treatment of osteomyelitis, a prolonged systemic antibiotic treatment such 
as the use of gentamicin, either oral or parenteral, for a period of 4±6 weeks, is known to cause 
systemic toxicity and patient discomfort. Therefore, localised drug delivery at the infected site, for 
example injecting drug loaded microspheres, is being proposed. By this method the risk of high dose 
administration and possibility of building drug resistance could be avoided [8]. In a study conducted 
by Huang et al. [8] PLA microspheres containing gentamicin were developed for the treatment of bone 
infection. PLA microspheres with an average size of 178 µm were incorporated with gentamicin 
sulphate for the treatment of osteomyelitis, where 80% of gentamicin sulphate was released within  
3 weeks of implantation [8]. 
Although these biodegradable polymers such as PLA prove to be advantageous since they can 
circumvent some of the problems faced when long term implants are used, they have a risk of toxicity 
and immunogenicity due to their acidic by-products. Other properties such as high price, lack  
of tailorability, presence of chemical catalysts and fast degradation rate has challenged their 
commercialization [9]. Thus the need for polyhydroxyalkanoates has arisen due to their tailorable 
mechanical properties, biocompatibility and biodegradability. 
In this paper, P(3HB) microspheres containing gentamicin for the treatment of bone infections such 
as osteomyelitis were developed. Localised drug delivery at the site of infection using these drug 
loaded microspheres is being proposed, for example incorporating the microspheres into 3D porous 
scaffolds [10]. The main advantage of the P(3HB) microspheres is the lack of risk of toxicity and 
immunogenicity due to acidic by products, which is a disadvantage when PLA is used [11,12]. In this 
work, the processing conditions that particularly affect the characteristics of the P(3HB) microspheres 
were investigated so that microspheres with a high gentamicin loading efficiency, controllable porosity 
and uniform drug distribution could be produced. 
2. Materials and Methods 
2.1. Materials 
Distilled water and high performance liquid chromatography (HPLC) grade water were used where 
appropriate. The two types of water were obtained from Elga Pure Lab Options distillation units. All 
chemicals, buffers and drugs used were purchased from Sigma-Aldrich (Dorset UK). Care was taken 
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to make sure that the chemicals used were of the best grade available (analytical or HPLC where 
appropriate) for the experiment.  
P(3HB) was isolated from the Gram-positive bacteria Bacillus cereus SPV which was obtained from 
the culture collection of University of Westminster, London, UK. All chemicals required for the 
growth of Bacillus cereus SPV and extraction of polymer from the bacterial cells were obtained from 
Sigma-Aldrich Company Ltd. and VWR Chemicals (England) except for nutrient broth and yeast 
extract, which was obtained from DIFCO (BD UK Ltd., Oxford, UK). Antifoam (FG-10) was 
purchased from Dow corning (Edison, NJ, USA) for fermentation study. 
2.2. P(3HB) Microsphere Production  
A solid-in-oil-in-water emulsion technique was used for P(3HB) microsphere preparation. 
Quantities of 1 or 3 g of P(3HB) were dissolved in 8 mL of chloroform and agitated for 3 min. This 
mixture was then transferred into the first solid-in-oil emulsion (w/o) of 40 mL of 1% or 0.5% w/v 
aqueous polyvinyl alcohol (PVA) solution, and stirred at 1000 rpm for 3 min. This solution was then 
added to a second solid-in-oil-in-water emulsion (w/o/w) of 500 mL of 0.5% or 0.05% w/v aqueous 
PVA solution, forming the second oil-in-water emulsion. This emulsion was stirred either at 300 rpm 
or 800 rpm for 4 h to eliminate the chloroform used as solvent and then to form P(3HB) microspheres. 
The resulting microspheres were isolated by centrifugation at 3680 g for 5 min and then washed with 
distilled water three times, air dried and stored in a desiccator until further use. Table 1 shows the 
varying processing conditions (amount of surfactant, polymer concentration and stirring rate) used for 
the synthesis of P(3HB) microspheres. 
Table 1. The varying processing conditions (amount of surfactant, polymer concentration 
and stirring rate) used for the synthesis of P(3HB) microspheres.  
Sample Polymer Concentration (g/L) PVA Concentration (%) Stirring Rate (rpm) 
1 1 0.5% 800 
2 3 0.5% 300 
3 1 1% 300 
4 3 1% 800 
2.3. Gentamicin Loaded P(3HB) Microsphere Production 
Gentamicin-loaded P(3HB) microspheres were produced using similar methods as described in 
section 2.2. In this case, 2 mg/g of P(3HB) mixed with gentamicin were dissolved in 8 mL of 
chloroform and agitated for 3 min. This solution was then added to the aqueous first solid-in-oil 
emulsion of 40 mL of 1% or 0.5% w/v aqueous polyvinyl alcohol (PVA) solution, and stirred at  
1000 rpm for 3 min. This solution was then added to a second solid-in-oil-in-water emulsion of 
500 mL of 0.5% or 0.05% w/v aqueous PVA solution, forming the second oil-in-water emulsion. This 
emulsion was stirred either at 300 rpm or 800 rpm for 4 h to eliminate the chloroform used as solvent 
and to form P(3HB) microspheres. The resulting microspheres were isolated by centrifugation at  
3680 g for 5 min and then freeze-dried (Savant Modulyo D Freeze-drier, Thermo Electron Corp, K) 
and stored at 4 °C until further use. 
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2.4. In Vitro Drug Release Studies 
The in vitro drug release experiments were performed in an incubator at 37 qC for 24 h.  
10 mg of the gentamicin-loaded microspheres were immersed in 2 mL of simulated body fluid (SBF) 
and 1 mL samples were collected at regular intervals, up to a final duration of 24 h. SBF was prepared 
following the study of Kukobo et al. [13]. SBF was used as it has similar ionic concentration as blood 
plasma. It is therefore important to identify whether or not the gentamicin encapsulated within the 
microspheres was released in a controlled manner when implanted in vivo. Each aliquot was replaced 
with fresh buffer and the tubes returned to the shaker. At each time point the samples were taken out  
in triplicates and the results averaged. The drug content was determined by injecting 15 µL of the 
samples onto a high-performance liquid chromatography (HPLC) column and the gentamicin 
concentration quantified using the standard curve. The experiments were repeated three times. 
2.5. Drug Quantification Methods 
The encapsulation efficiency (EE%) of the drug-loaded microspheres prepared under different 
conditions as mentioned in Section 2.2. was determined using Equation 1. 
EE% = experimental drug loading/actual drug loading (1)  
To determine the EE values, 5 mg of the drug loaded microspheres were dissolved in 1 mL of 
chloroform, to which 5 mL of water was added after the microspheres were well dissolved. Drugs used 
in this study, being hydrophilic in nature, separated into the water phase on vortexing. The water phase 
was then analysed for the drug content using liquid chromatography-mass spectrometry (LC±MS). 
2.5.1. Liquid Chromatography Mass Spectrometry  
Liquid Chromatography Mass Spectrometry (LC-MS) was used for analysing the drug content  
from the release buffer. 15 µL samples collected at different time points were injected onto the HPLC 
column (Dionex HPLC) coupled with an atmospheric pressure (AP)-electrospray ionization (ESI) mass 
spectrometer (Dionex). Separation was carried out at 50 qC on a reversed-phase C18 60 RP column of 
dimensions 250 mm × 4 mm [7].  
2.5.2. Mobile Phase used for Gentamicin Quantification  
The mobile phase used for gentamicin quantification was an isocratic flow of 60% 
pentafluoropropionic acid (20 mM in ultra-pure water from Fluka Chemicals, Bucks, Switzerland) and 
40% methanol. The standard curve was plotted for gentamicin concentrations ranging between 1.0 and 
2000 ȝg mLí1 [7]. 
2.6. P(3HB) Microsphere Characterization Techniques  
2.6.1. Particle size Analysis 
Malvern Mastersizer particle size analyser (Worcestershire, UK) was used to measure the particle 
size of the microspheres. Microspheres were dispersed well in water and following a background 
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measurement; the suspensions were added drop wise to the analyser until the ideal concentration  
was reached.  
2.6.2. Surface Morphology and Microstructure Characterization  
P(3HB) microspheres were observed using a JEOL 5610LV scanning electron microscope (SEM). 
The samples were placed on 8 mm diameter aluminum stubs using a sticky tag to hold the sample. A 
gold sputtering device (EMITECH-K550) was used to coat the samples, operating at a pressure of  
7 × 10í2 bar and deposition current of 20 mA for 2 min; images were taken at various magnifications 
to analyse the samples.  
2.6.3. Porosity 
The porosity (İof the microspheres was measured using the liquid displacement method. Briefly,  
5 mL of ethanol was used as the displacement liquid in a measuring cylinder and weighed. The 
P(3HB) microspheres immersed in ethanol in the cylinder were sonicated in a water bath to assist 
penetration of ethanol within the pores. 
   2 3the volume of the matrix pores /p S eV W W W U    (2)  
   1 2the volume of the matrix polymer phase /s S eV W W W U    (3)  
     2 3 1 3/ /p p s SV V V W W W W WH        (4)  
W1 is the weight of the cylinder filled with ethanol before the immersion of the microsphere sample,  
W2 is the weight of the cylinder, the ethanol and the sample after removing the excess ethanol above 
the 5 mL mark, W3 is the weight of the cylinder and ethanol after removing the microsphere sample 
saturated with ethanol, and Ws is the weight of the microsphere sample used in the measurement.  
2.6.4. Determination of Residual PVA Content  
The % residual PVA content present on the surface of the microspheres prepared using different 
conditions were determined by the formation of a coloured complex between two adjacent hydroxyl 
groups of PVA and an iodine molecule [14]. Briefly, 2 mg of the lyophilized microsphere samples 
prepared using the different conditions were treated with 2 mL of 0.5 M sodium hydroxide (NaOH) for 
15 min at 60 qC. Each of the samples was then neutralized with 900 µL of 1 N hydrochloric acid (HCl) 
and the volume was adjusted to 5 mL with distilled water. To each of the samples, 3 mL of  
0.65 M solution of boric acid, 0.5 mL of iodine solution (I2)/Potassium iodide (KI) (0.05 M/0.15 M) 
and 1.5 mL of distilled water were added. Finally, the absorbance of the samples was measured at  
690 nm (Novaspec II Visible spectrophotometer, UK) after 15 min of incubation. A standard graph for 
quantification of PVA was also prepared under identical conditions [14]. 
2.6.5. Determination of Surface Hydrophobicity  
1 mg microsphere samples prepared using different conditions, as mentioned in Section 2.1, were 
incubated with different concentrations of Rose Bengal dye (4±20 µg/mL) for 3 h at room temperature. 
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The samples were then centrifuged at 110,000 g for 30 min in a microcentrifuge (Sorvall legend RT, 
UK) to spin down the particles. The supernatant from each of the samples was analysed at  
542.7 nm (Novaspec II Visible spectrophotometer, UK) to determine the unbound dye. The dye 
solution without any microspheres was used as a control and run each time under the same condition to 
account for the dye bound to the centrifuge tubes [14]. 
2.6.6. Bovine Serum Albumin (BSA) Adsorption Test  
In order to determine the protein adsorption onto the surface of the microspheres 25 mg of the 
microspheres prepared using different conditions, as mentioned in Section 2.2, were added to 5 mL of 
distilled water containing 1 mg of BSA. The microspheres were then removed by centrifugation and 
the concentration of BSA in the supernatant after adsorption on the surface of the microspheres was 
determined using UV spectroscopy (Eppendorf Biophotometer, UK). The absorbance was measured at 
280 nm wavelength. A calibration curve was prepared using known concentrations of BSA. The 
protein adsorbed (q) on the surface of the microspheres was calculated using Equation 3.  
q =  V (Ci ± Cf)/m (5)  
where Ci and Cf are the initial and final BSA concentrations concentration in the supernatant after 
adsorption studies, respectively; V is the total volume of the solution (5 mL); and m is the weight of the 
microspheres added into the solution [15]. 
2.6.7. Specific Surface Area Measurement  
The specific surface area (SSA) of the microspheres was measured according to Brunauer-Emmett-
Teller (BET) method, with nitrogen adsorption at 77 K. The physical adsorption of nitrogen gas 
molecules on a solid surface was measured using a Micromeritics Tristar instrument after degassing 
for 1 h at 150 °C. The particle diameter (dBET) for the P(3HB) microspheres was calculated from the 
SSA value, using Equation 6: 
dBET= 6/(ȡ × SSA) (6)  
where ȡ= density of P(3HB), i.e., 1.26 g/cm3 and SSA = specific surface area. 
2.6.8. Zeta-Potential Analysis  
2 g of the P(3HB) microspheres mixed with water were stirred using a magnetic stirrer for  
30 min. Following that, the microspheres were centrifuged and re-dispersed in 5 mL of water and 
stirred once again for 30 min. Water was used as the dispersant for the microspheres to measure their 
zeta-potential. The zeta-potential analysis of the microspheres was measured using an Agilent 7020 
Zeta Probe (Foster City, USA). 1N NaOH and 1N HCl solutions were added as necessary to adjust  
the pH [15].  
2.6.9. X-ray Photoelectron Spectroscopy (XPS)  
The surface chemistry of the gentamicin loaded microspheres was analysed using XPS (Cardiff 
Catalysis Institute, Cardiff). An Axis Ultra DLD system (Kratos Axis Ultra., Cardiff, UK) with the 
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following acquisition parameters; monochromated 120 W X-ray Power (10 mA emission × 12 kV),  
20 eV Pass energy, Analysis Area (700 × 300 ȝm2) was used to analyse the samples.  
3. Results and Discussion  
3.1. P(3HB) Microsphere Preparation and Characterization  
P(3HB) microspheres were prepared by the solid-oil-in-water (s/o/w) technique using different 
conditions presented in Table 1. In order to optimise the microspheres for maximum encapsulation 
efficiency the conditions for microsphere preparation including polymer concentration, surfactant 
concentration and stirring rate were varied. The selected processing conditions, shown in Table 1, were 
determined using a comprehensive investigation described elsewhere [16]. 
The particle size distribution curve of the P(3HB) microspheres prepared using different conditions 
shown in Table 1 are represented in Figure 1 (A, B, C, D). It was found that the size range of the 
measured particles was around 1±10 µm, where 90% of the measured particles had a mean particle size 
ranging from 1.5 to 2.0 µm and 80% of the microspheres had diameters below 5 µm. 
Figure 1. Size distribution analysis of P(3HB) microspheres prepared using different 
conditions (Table 1). (A) sample 1; (B) sample 2; (C) sample 3; (D) sample 4. 
 
3.2. Effect of Polymer Concentration on Particle Size 
The amount of P(3HB) used per unit volume of the solvent in this study was varied from 1 g to 3 g, 
respectively. Microspheres prepared under conditions 1 and 2 had an average size of 1.7 µm and 2 µm, 
as shown in Figure 1A,B respectively. These microspheres were slightly larger than microspheres 
C 
A B 
D 
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prepared under conditions 3 and 4 (Figure 1C,D) which were of mean size 1.58 µm and 1.54 µm, 
respectively. The effect of varying the polymer concentration on the final microsphere structure was 
studied. The size of microspheres prepared using lower concentrations of P(3HB), such as the 
microspheres prepared using conditions 1, were slightly smaller than the microspheres prepared using 
higher concentrations of P(3HB) (condition 2). It was observed that at higher concentrations of the 
polymer in the emulsion phase, the viscosity of the solution increases. At higher viscosities the 
solution is difficult to disperse due to which slightly larger microspheres are produced [6,17]. 
However, microspheres prepared using conditions 4 with polymer concentrations of 3 g/L exhibited a 
smaller particle size when compared to the microspheres prepared using conditions 3. Although the 
increasing polymer concentration of 3 g/L in condition 4 had increased the viscosity of the emulsion 
phase, other factors such as surfactant concentration and stirrer speed would have dominated, 
contributing to the small size of the microspheres.  
3.3. Effect of the Surfactant Concentration on Microsphere Size  
Polyvinyl alcohol (PVA) concentration, which was used as a surfactant, was varied from 0.5% w/v 
to 1% w/v, as shown in Table 1. For conditions 1 and 2 (sample 1 and 2, Table 1), a lower PVA 
concentration of 0.5% w/v was used and in conditions 3 and 4 (sample 3 and 4, Table 1), a PVA 
concentration of 1% w/v was used in the emulsion phase. The mean particle size, as seen from  
Figure 2, increased with the decrease in PVA concentration in the emulsion phase.  
Figure 2. The effect of surfactant concentration on the P(3HB) microsphere sizes.  
 
 
In addition, the microspheres prepared using conditions 3 and 4 had a smoother finish to the surface 
and were not coalesced together. An optimal viscosity of the emulsion phase is often required as this 
prevents the solids from precipitating out of the solution leading to the formation of smoother finished 
microspheres [6]. For example, in a study conducted by Yang et al. [6] it was observed that at lower 
PVA concentrations such as 0.025% w/v, the water droplets inside the microspheres coalesced with 
each other, thereby forming interconnecting water channels which increased the release rate of BSA. 
These water channels then increased in size, eventually leading to the collapse of the microspheres [6]. 
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Higher concentrations of PVA on the other hand are known to increase the viscosity of the external 
phase, thus making it increasingly difficult to break the emulsion droplets into smaller sizes. Hence, 
larger microspheres are produced. However, in this study only slight differences in the microsphere 
sizes were observed with increasing PVA concentrations as there is a maximum PVA concentration 
which influences the size of the microsphere beyond which an increase in the viscosity (due to the 
PVA concentration) does not have any further influence on the size of the microspheres and the stirrer 
speed was found to be the dominant factor.  
Once the microspheres were prepared they were washed 3 times with water to remove any residual 
PVA present on the surface. Residual PVA on the surface of microspheres can have a significant effect 
on the physical properties, such as surface charge, surface hydrophobicity, in vitro drug release rate 
and rate of protein adsorption [6]. In this study, despite the washings, residual PVA was still found 
associated with the microspheres. Samples 1 and 2 (conditions 1 and 2) exhibited lower percentages of 
residual PVA, which were 0.14% and 0.13% when compared to 0.6% and 0.54% of residual PVA 
present in samples 3 and 4 (conditions 3 and 4, Table 1). After solvent evaporation, PVA is generally 
known to be bound irreversibly on the surface of the microspheres. The amount of PVA that binds to 
the curvature of the microspheres is dependent on microsphere size [18]. It was observed by  
Lee et al. [18] that with the decrease in microsphere size and increase in PVA concentration, the PVA 
transfer rate from the oil/water interface onto the newly formed curved interface of the microsphere 
increased. This observation was in agreement with the results obtained in this study, where an increase 
in the PVA content on the surface of the microspheres was observed when the PVA concentration in 
the external phase was increased. Lee et al. [18] also observed that when PVA concentrations of  
0.1% w/w, 1% w/w and 10% w/w were used, the PVA content on the surface of the PLGA 
microspheres was 7.4 mg/g, 15.2 mg/g, and 23.7 mg/g respectively. 
3.4. Effect of Stirring Rate on Microsphere Size  
In order to study the effect of stirring rate on microsphere size, the stirring rate was maintained at 
300 rpm and 800 rpm in the final emulsification step under varying PVA and P(3HB) concentrations. 
The microsphere sizes were 1.7 µm and 1.54 µm when prepared under conditions 1 and 4 (Table 1), 
with a stirrer speed of 800 rpm. Similarly, the microspheres prepared under conditions 2 and 3 (Table 1), 
with a stirrer speed of 300 rpm exhibited average sizes of 2 µm and 1.58 µm, respectively. It has been 
previously observed that at an increased stirring rate of 800 rpm, the microsphere size is significantly 
reduced [16,19]. From the results obtained in this study, it can be concluded that the stirrer speed may 
have contributed to the small size of the microspheres. A highly viscous solution is difficult to disperse 
at a lower stirrer speed, due to which larger sized microspheres are produced. Martin et al. [20] 
observed the formation of larger P(3HB) microspheres of (100 µm to 250 µm) when the stirrer speed 
was reduced to 500 rpm when compared to the smaller microspheres (5 to 10 µm) produced when the 
stirrer speed was 800 rpm. Similar observations were made in this study; using a higher stirrer speed of 
800 rpm, smaller sized microspheres were produced when compared to those produced at 300 rpm. 
The stirrer speed should provide the required energy to disperse the oil phase in water producing 
smaller sized microspheres. It was also observed that the average microsphere size in this study varied 
from 1 to 5 µm despite the increasing viscosity of the emulsion phase in the presence of both PVA and 
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polymer. In this study, therefore the stirrer speed had a dominant effect on the microsphere size as 
there is a maximum viscosity which influences the size of the microsphere beyond which an increase 
in the viscosity due to the PVA and polymer concentration does not have any further influence on the 
size of the microspheres. 
3.5. Effect of Stirring on Microsphere Surface Area 
The specific surface area of the microspheres varied depending on the different conditions used as 
represented in Figure 3. An increase in the specific surface area would be expected with a decrease in 
the average particle size. Microspheres with an average particle size of 1.54 µm and 1.58 µm in 
diameter (sample 3 and sample 4, Table 1) exhibited a specific surface area of 9.60 m2/g and  
9.52 m2/g, respectively. Whereas, microspheres with slightly larger particle size of 2 µm and 1.7 µm in 
diameter (sample 1 and sample 2, Table 1), exhibited a decrease in the specific surface area being  
6.05 m2/g and 9.4 m2/g.  
Figure 3. The specific surface area of P(3HB) microspheres prepared using different 
conditions (Table 1) measured by BET analysis.  
 
Microspheres with a higher specific surface area also exhibited an increase in the higher % residual 
PVA adsorbed on the surface. Researchers like Poletto et al. [21] have also observed an increase in the 
specific surface area, from 33 m2/g to 120 m2/g, of P(3HB-co-3HV) microspheres when the particle 
size was reduced from 360 µm to 190 µm. 
3.6. Surface Morphology 
The surface morphology of microspheres using different conditions was observed by SEM  
(Figure 4). Microspheres prepared under the different conditions (Table 1), appeared spherical in 
shape, with a smooth surface morphology.  
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Figure 4. (SEM) of  P(3HB) microspheres prepared under different conditions described in 
Table 1: (A) sample 1; (B) sample 2; (C) sample 3; (D) sample 4. 
 
The type of solvent is known to influence the surface morphology of microspheres. In this study 
chloroform was chosen as the solvent as opposed to dichloromethane due to lesser miscibility of 
chloroform in water, which is 1 in 200 parts when compared to dichloromethane, which is 1 in 
50 parts [14]. An increased amount of PVA is known to partition into the polymer phase when the 
organic solvent exhibits an increased miscibility in water because of higher hydrophilicity [14]. Thus 
in order to avoid a higher deposition of residual PVA on the surface of the microspheres chloroform 
was used as the solvent.  
3.7. Surface Hydrophobicity  
The surface hydrophobicity of microspheres fabricated using higher and lower concentrations of 
PVA was determined by comparing the amount of hydrophobic Rose Bengal dye that was adsorbed 
per mg of the microspheres. As seen in Figure 5, the amount of Rose Bengal bound to the surface of 
the microspheres decreases with the increase in PVA concentration. Microspheres fabricated under 
conditions 3 and 4 (Table 1) exhibited a higher % residual PVA and hence bound a lower amount of 
Rose Bengal dye when compared to the microspheres fabricated under conditions 1 and 2 (Table 1). 
For example, at the highest concentration of 12 mg/mL of Rose Bengal dye, the microspheres prepared 
under condition 3 and 4 bound 0.63 mg/mg and 0.72 mg/mg of the dye in contrast to the higher values 
of 1.03 mg/mg and 1.07 mg/mg measured for microspheres prepared under conditions 1 and 2. 
A B 
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Figure 5. Amount of Rose Bengal Dye bound onto the surface of P(3HB) microspheres 
(sample1, sample 2, sample 3, sample 4) as a function of an increase in Rose Bengal  
dye concentration.  
 
Microspheres fabricated with a higher PVA (1%) concentration appeared to be more hydrophilic in 
nature as compared to those that were formulated with 0.5% PVA, as seen from the lesser amounts of 
Rose Bengal Dye bound to their surfaces. In a relevant study Sahoo et al. [14] observed a lower 
binding of 0.005 µg/mL of Rose Bengal dye on the surface of nanoparticles which were formulated 
with 5% PVA when compared to 0.024 µg/mL bound on nanoparticles formulated with a 0.5% PVA 
concentration. During microsphere preparation, hydrophobic ends of PVA penetrate into the organic 
phase and interact with P(3HB) microspheres due to which an irreversible binding of PVA occurs on 
the microsphere surface when the solvent evaporates. An increased amount of PVA is known to 
partition into the polymer phase when the organic solvent exhibits an increased miscibility in water 
because of higher hydrophilicity. Since PVA is a hydrophilic polymer, the higher amount of residual 
PVA on the surface of the microspheres would have accounted for the higher hydrophilicity. 
3.8. Zeta-Potential Analysis  
Microspheres prepared with a higher PVA concentration in conditions 3 and 4 (Table 1), at pH 7 
exhibited much lower negative zeta-potential values of í14.2 mV and í14 mV when compared to the 
zeta-potential values of í32.2 mV and í33.7 mV for the microspheres prepared under conditions 1 
and 2 (Table 1), as seen in Figure 6. 
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Figure 6. Zeta-potential values of P(3HB) microspheres fabricated using different 
conditions (Table 1) at pH 7. 
 
From the zeta-potential-pH profiles it was observed that all microspheres exhibited a negative 
surface charge at pH 7, as shown in Figure 6. However at a lower pH, the microspheres exhibited a 
positive zeta-potential value (Figure 7). Microspheres fabricated using conditions 3 and 4 (Table 1) 
exhibited lower positive zeta-potential charge when compared to microspheres fabricated using 
conditions 1 and 2 (Table 1). 
Figure 7. Zeta-potential values of P(3HB) microspheres fabricated using different 
conditions (Table 1) at different pH values. 
 
The zeta-potential values reflect the change in the surface charge due to the deposition of PVA on 
the surface of the microspheres [22]. The COOH groups on microsphere surfaces exhibit a negative 
charge due to deprotonation at pH 7; however at a lower pH a charge reversal from negative to positive 
was observed. This phenomenon was observed for all microspheres prepared using different 
conditions. Similarly, decrease in positive zeta-potential values were observed when the concentration 
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of residual PVA on the surface of microspheres was increased. Often non-ionic surfactants such as 
PVA are known to strongly adhere on the microsphere surface by anchoring the hydrophobic tail into 
the polymer only when it is hydrophobic, leaving the polar head protruded on the surface [14]. During 
microsphere preparation, hydrophobic ends penetrate into the organic phase and interact with P(3HB) 
microspheres due to which an irreversible binding of the PVA occurs on the surface of microspheres 
when the solvent evaporates. Thus, when P(3HB) is fabricated into microspheres, PVA used as a 
surfactant coats the surface thereby shielding the surface charge of PHB. Due to this effect, P(3HB) 
processed into microspheres carries a much less negative charge at neutral pH when compared to the 
negative charge of the neat P(3HB) (í40 mV at neutral pH). In acidic solutions such as pH < 4.0, C=O 
of the ester present on the surface of microspheres gets protonated. As a result, at lower pH the 
negative surface charge is reversed to a positive surface charge. Similar observations were made by 
Lee et al. [18] who showed that with an increase in PVA concentration from 0.5% to 5%, the  
zeta-potential values of the PLGA nanoparticles decreased from í15.4 mV to í8.0 mV at neutral pH. 
However in acidic solutions (pH < 5.0), the zeta-potential values of microspheres with lower PVA 
concentration (0.5% w/v) showed a relatively high positive charge when compared to the lower surface 
charge of microspheres prepared with higher PVA concentration (1% w/v) [18]. 
3.9. Effect of Zeta-Potential on Protein Adsorption  
The changes in the surface properties of the microspheres can have a significant impact on their use 
in biological applications [15]. Thus in this study protein adsorption in the presence of varying surface 
charges was studied. The comparison of protein (BSA) adsorption and zeta-potential of microspheres 
fabricated under different conditions is represented in Figure 8. It is observed that, microspheres 
prepared under conditions 3 and 4 (Table 1), adsorbed a slightly higher amount of protein, i.e.,  
327 mg/g and 324.4 mg/g, when compared to 315 mg/g and 240 mg/g, the amount adsorbed on the 
microspheres prepared under conditions 1 and 2. 
In this study, a higher amount of protein was adsorbed on microspheres with a lesser negative 
charge when compared to those with a higher negative charge. BSA adsorption on the surface of an 
adsorbent at neutral pH occurs due to electrostatic interaction. Since BSA is negatively charged at 
neutral pH and the microspheres fabricated using different conditions also exhibited a negative surface 
charge at neutral pH, other interactive factors such as van der Waals forces, and steric interactions 
would have contributed to the protein adsorption [23]. Similar observations were made by Patil et al [15] 
where 10 mg/mg (nanoparticles) of BSA adsorption on nanoparticles with a negative charge of  
í17.72 mV was observed. However, 67.40 mg/mg of BSA was adsorbed on cerium oxide 
nanoparticles with a zeta-potential of 59.32 mV. The authors observed an increasing BSA adsorption 
on nanoparticles with a positive zeta-potential charge, confirming that the electrostatic interaction was 
the primary reason for protein adsorption [15].  
 
Int. J. Mol. Sci. 2011, 12 4309 
 
Figure 8. Amount of BSA adsorbed on the surface of P(3HB) microspheres (sample 1, 
sample 2, sample 3, sample 4) as a function of zeta-potential.  
 
3.10. Determination of the Drug Encapsulation Efficiency in P(3HB) Microspheres 
In order to achieve higher drug loadings, the effects of polymer concentration, PVA concentration 
and stirring rate on encapsulation efficiency during microsphere preparation was investigated. In this 
study, gentamicin was investigated with an initial drug loading of 2 mg/g in P(3HB) microspheres 
fabricated using the different conditions described in section 2.1.  
Microspheres prepared under condition 4, with the smallest particle size, exhibited the highest 
encapsulation efficiency of 48% when compared to microspheres produced using other conditions. 
Sendil et al. [24] also observed an increase in the encapsulation efficiency with a decrease in 
microsphere size. P(3HB-co-3HV) microspheres with an average diameter of 399 µm exhibited lower 
encapsulation efficiency of (20.2%) when compared to 30.1% encapsulation efficiency exhibited by 
smaller microspheres (340 µm) [24]. It was suggested that the faster rate of solvent removal in 
microspheres with a smaller size led to the rapid entrapment of the drug. Similarly, in this study the 
highest entrapment of a highly hydrophilic drug such as gentamicin occurred in the microspheres with 
the smallest particle size due to the rapid solvent evaporation rate.  
Microspheres fabricated with higher concentrations of PVA are known to yield stable emulsions 
which prevent the transfer of the encapsulated hydrophilic drugs/proteins into the surroundings; as a 
result the drug/protein is more evenly distributed within the interior of the microspheres [6]. This could 
also explain the higher encapsulation efficiency of gentamicin in P(3HB) microspheres fabricated with 
a higher PVA concentration used in this study, when compared to the lower encapsulation of 11% 
observed within P(3HB) microspheres fabricated with a lower PVA concentration.  
Also, variations in the polymer/drug ratio influence the encapsulation efficiency [22]. In the 
presence of high concentrations of the polymer and fixed drug concentrations, higher concentrations of 
the drug are encapsulated within the microspheres [22]. This could be another reason why higher 
encapsulation efficiency was observed in sample 4 (Table 1), where an increased polymer concentration 
Int. J. Mol. Sci. 2011, 12 4310 
 
of 3 g was used. Microspheres prepared by condition 4, Table 1, exhibiting the highest encapsulation 
efficiency, were chosen for further drug release studies. 
3.11. Determination of Drug-Polymer Interaction  
The surface chemistry of microspheres with the highest encapsulation efficiency of 48% was 
investigated using XPS. As shown in Figure 9, the presence of carbon, nitrogen and oxygen on the 
surface of the gentamicin-loaded microspheres was examined using soft X-Ray excitation. Nitrogen 
present in gentamicin was used to estimate the amount of drug entrapped during the microsphere 
fabrication procedure. The surface chemical composition of the tested sample was found to be: 67.29% 
carbon, 31.25% oxygen and 1.05% nitrogen. The binding energy of nitrogen N-1s is Eb = 399.5 eV 
which corresponds to the single bonded nitrogen, as shown in Figure 9B. The binding energy of 
nitrogen N-1s present on the gentamicin-loaded microspheres was found to be 396.13 eV, which was 
quite close to the value for singly bonded nitrogen. 
Figure 9. (A) Typical XPS spectra of gentamicin loaded P(3HB) microspheres;  
(B) Magnification of the nitrogen peak with a binding energy of 396.13 eV. 
 
The assessment of gentamicin adsorption on the microsphere surface prepared under condition 4 
(Table 1) was done on the basis of nitrogen content present on the samples since nitrogen is unique to 
the drug and is absent in the P(3HB) microspheres. From the XPS data a significant increase in 
nitrogen content on the surface of gentamicin loaded samples, was observed, when compared to 
unloaded P(3HB) microspheres, where, as expected, only carbon and oxygen were detected. This result 
therefore indicated that apart from being encapsulated, some amount of gentamicin was bound onto the 
microsphere surface. Similar results were observed by Naraharisetti et al. [9] who also observed the 
presence of surface bound drugs (gentamicin) on microspheres made using poly-L-lactide (PLLA) and 
DL-lactic-co-glycolic acid (PLGA).  
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3.12. In Vitro Release Studies 
The cumulative in vitro release of gentamicin from P(3HB) microspheres prepared using  
condition 4 (sample 4) is shown in Figure 10. In this study the release profile is seen to be bimodal, 
with an initial burst release followed by controlled continuous release. Gentamicin released from 
microspheres in the SBF solution at 37 qC and pH 7.4 was measured after periods of 1 h, 5 h, 12 h and 
20 h. During the initial burst release phase (0 min to 1 h) the amount drug released was 90.6 µg/mL, 
which was 60% of the total encapsulated drug. This phase was followed by the controlled release 
period which occurred from 5 h to 12 h, where small amounts of the drug, i.e., 24.6 µg/mL to 18 
µg/mL, slowly diffused from the microspheres into the release buffer. Finally, after 20 h, the 
cumulative drug release was 95.33%.  
Figure 10. In vitro gentamicin release profile from P(3HB) microspheres in SBF (sample 4). 
 
The in vitro drug release rate is largely dependent on the size of the microspheres [6]. Larger 
microspheres (100±300 µm) tend to release the drug slowly and for a much longer time when 
compared to smaller microspheres [25]. This slow release is due to the reduced drug diffusion path 
within the microspheres and the decreased specific surface area of larger microspheres when compared 
to smaller microspheres. Thus in this study, drug release within a period of 24 h was observed which 
can probably be attributed to the small size (1.54 µm in diameter) of the microspheres.  
The in vitro drug release is also dependent on the drug distribution within the microspheres. The 
high initial burst release is often attributed to the presence of surface associated drugs [17]. In this 
study gentamicin, in addition to being encapsulated within the microspheres, was also adsorbed on the 
surface of the microspheres, as confirmed by XPS analysis. As a result, an initial burst release of 60% 
of the total encapsulated drug was recorded. After the initial burst release, a slow and controlled 
release of the drug was observed. Often factors such as the type of encapsulated drug and polymer 
determine the rate of slow and sustained release [21]. In this study, a sustained release phase from  
5 h to 12 h was observed where small amounts of the drug slowly diffused from the microspheres into 
the release buffer. The length of the sustained release phase of polymeric matrices is largely dependent 
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on the type of polymer used [9]. Polymers are known to undergo degradation either by surface erosion 
or bulk degradation or a combination of both. With the increase in the penetration of water molecules 
into the polymeric matrix, homogenous surface erosion starts to occur which is followed by bulk 
degradation. In this study, the total drug cumulative release of 95.33% was found to occur within a 
period of 20 h, therefore, drug release by either surface erosion or degradation was not considered due 
to the slow degradable nature of the polymer. The drug release in the final stage occurred most likely 
through the water channels that were created by the diffused drugs. Further in this study it was 
observed that in the presence of the hydrophilic drug and PVA, the water uptake rate of the polymer 
was accelerated, thereby having a significant impact on drug release.  
4. Conclusions 
A solid-in-oil-water (s/o/w) technique was used to produce tailored poly(3-hydroxybutyrate) 
P(3HB) microspheres. The effect of several parameters such as polymer concentration, surfactant 
concentration and stirring rate were investigated regarding their influence on microsphere properties, 
shape and dimensions. The average size of the microspheres varied from 2 µm to 1.54 µm with 
specific surface areas from 9.60 m2/g to 6.05 m2/g. Microspheres produced using low stirring rates of 
300 rpm exhibited slightly larger size than the microspheres produced when the stirring rate was 
increased to 800 rpm. The presence of residual PVA on the surface of the microspheres affected 
several properties of microspheres such as zeta-potential, surface hydrophobicity, protein adsorption 
and encapsulation efficiency. The surface and internal morphology, drug distribution and release 
kinetics of microspheres exhibiting the highest encapsulation efficiency (48%), were investigated. The 
hydrophilic nature of the drug also had an influence on the drug release behaviour. The in vitro release 
of gentamicin in SBF was bimodal where an initial burst release was observed followed by a diffusion 
mediated sustained release. The knowledge gained in this work about the different factors influencing 
the drug release from P(3HB) microspheres will have important implications for the development of 
drug delivery vehicles exhibiting controlled delivery of potent drugs for various medical applications 
and for tissue engineering therapeutics. 
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